We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How Business e-services customers can view services that they ordered today and the previous 6 days through the portal.
Permitted descriptions for gold plated silver articles at point of sale in the UK.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Supplier declarations are where your UK supplier provides you with information needed to prove the origin of your goods for preferential rates of duty between the UK and other countries.
How bottled water producers can get a natural mineral water recognised in England, and rules you need to follow to produce and label it.
What blood establishments, blood banks and manufacturers of blood products need to do to ensure the safety and quality of blood and blood products.
Requirements for an evaluation of the 2011 and 2012 NCS pilots.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Information for pregnant women who are offered a chorionic villus sampling (CVS) or amniocentesis diagnostic test.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
Information to help healthcare professionals speak with parents at risk of having a child with sickle cell disease.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Guidance for exporting nuclear equipment, material and technology that appears on what is known as the 'Trigger List'.
Responsibilities of the principal accountable person for a high-rise residential building’s safety case report.
Information for pregnant women to understand what it means to be a delta beta thalassaemia.
This guidance relates to the legal criteria for determining whether a building is considered a higher-risk building under the Building Safety Act 2022 and the Higher-Risk Buildings (Descriptions and Supplementary Provisions) Regulations 2023. It relates to the definition of higher-risk...
Information for parents to explain what it means to have a positive screening result for carrying the cystic fibrosis (CF) gene.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Definitive fees charged for applications under Schedule 7 of the Veterinary Medicines Regulations 2013.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.